Topic
IPO
617 published works
China Law Update Blog
The New Chinese Growth Enterprise Market Is Launched — Stock Transfer Duties On “State-Owned” VC Firms and PE Funds?
On March 31, 2009, the China Securities Regulatory Commission ("CSRC"), the nation’s securities watchdog, issued the Measures on Administration of Initial Public Offering and Listing on the Growth Enterprise Market…
Securities Law Prof Blog
Spindler on IPO Underpricing
IPO Underpricing and Disclosure, by James C. Spindler, University of Southern California Law School, was recently posted on SSRN. Here is the abstract:Using a unique data set, I find that…
InsureReinsure
$586 Million Global Settlement Reached in the IPO Securities Litigation
After almost eight years of litigation, years of mediation, and failed partial settlements, the coordinated cases captioned as In re Initial Public Offering Securities Litigation (21-MC-92) appear to be on…
The D&O Diary
IPO Laddering Cases Settled for $586 Million
The consolidated IPO Laddering Cases, that superannuated vestige of a long-gone era that has continued to grind on despite numerous procedural setbacks, apparently has been settled (again), at least according…
Securities Law Prof Blog
SEC Files Complaint Against BarrierMed for Offering Fraud
The SEC filed a Complaint For Injunctive Relief today in the United States District Court for the Middle District of Florida against BarrierMed, Inc. (BarrierMed) and BarrierMed Glove Co. (BarrierMed…
The D&O Diary
First the IPO, Then the Lawsuit?
That sure didn’t take long. GT Solar International completed its $500 million IPO on July 23, 2008. Then on August 1, 2008, a mere seven trading days later, the…
North Carolina Business Litigation Report
Voyager Pharmaceutical Corp. v. Bowen, April 15, 2008 (Jolly)(unpublished)
"Choice of Law" "Aiding and Abetting Breach Of Fiduciary Duty"
North Carolina Business Litigation Report
Fiduciary Duty Claims Can Proceed Against Director And Employee Who Allegedly Sank $100 Million IPO
Voyager Pharmaceutical Corp. v. Bowen, April 15, 2008 (Jolly)(unpublished) Voyager, a company engaged in pharmaceutical research directed at slowing or halting Alzheimer's disease, was attempting a $100 million public offering…
The D&O Diary
IPO Laddering Case Dismissal Motion Substantially Denied
Subprime litigation may be all the rage, but the consolidated IPO Laddering case is back in the news, a seemingly distant reverberation from a long-gone era that may nonetheless still…
Securities Law Prof Blog
Wang, Winton & Yu on IPO Fraud
Corporate Fraud and Business Conditions: Evidence from IPOs, by TRACY YUE WANG, University of Minnesota - Twin Cities - Carlson School of Management, ANDREW WINTON, University of Minnesota - Twin…